Brown Technology Innovations

Brown Biomedical Innovations to Impact (BBII)

Brown Biomedical Innovations to Impact (BBII) is a translational commercial development program that supports the development of biomedical technologies by helping bridge the funding gap between early-stage biomedical innovations and well-defined commercial opportunities that are attractive to industry partners and investors. ​

BBII Support

BBII support includes providing strategic, monetary, and advisory support for well-defined research projects.​

  • Funding translational research projects - BBII Pilot awards up to $100,000 for 12 months (with possibility of renewal) and Brown Innovation Fund awards up to $250,000 for two years.
  • Advising/coaching – by an independent panel of advisors with broad expertise in evaluation, investment and commercialization of biomedical technologies.
  • Partnering/managing – BBII will identify and retain consultants and contract research organizations to leverage development expertise and provide project management support to ensure focus and timely delivery on project milestones.
  • Exploring commercial development opportunities – As opportunities progress, BBII and Brown Technology Innovations will work through established relationships with industry, venture capital, and entrepreneurial start-up resources to find the best path for further development.

Read about recently funded research projects.

How to Apply

The newly established Brown Innovation Fund, possible through generous philanthropic gifts, is intended for granting Life Sciences Impact Awards to Brown Faculty to support development of life sciences technologies with the potential to achieve commercialization.
Brown Biomedical Innovations to Impact (BBII) is a program to support innovative proof-of-concept projects with the goal of facilitating the translation of biomedical research discoveries through partnerships with industry and startups